Literature DB >> 16327331

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection.

Jonas Klingström1, Lindvi Gudmundsdotter, Bartek Zuber, Jorma Hinkula, Andreas Mörner, Britta Wahren, Erik Rollman.   

Abstract

The impaired functional activity of cytotoxic T lymphocytes and natural killer cells during HIV-1 infection has recently been attributed to decreased intracellular levels of perforin and granzyme B. In sera from individuals chronically infected with HIV-1 we report increased levels of extracellular perforin compared with uninfected individuals. Increased perforin was also observed during experimental SIV/SHIV infection. The combination of reduced intracellular perforin levels and an increased serum level indicates that HIV infection induces aberrant perforin secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16327331     DOI: 10.1097/01.aids.0000196170.57927.e1

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin.

Authors:  Jonas Klingström; Jonas Hardestam; Malin Stoltz; Bartek Zuber; Ake Lundkvist; Stig Linder; Clas Ahlm
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection.

Authors:  Nada Pitabut; Shinsaku Sakurada; Takahiro Tanaka; Chutharut Ridruechai; Junko Tanuma; Takahiro Aoki; Pacharee Kantipong; Surachai Piyaworawong; Nobuyuki Kobayashi; Panadda Dhepakson; Hideki Yanai; Norio Yamada; Shinichi Oka; Masaji Okada; Srisin Khusmith; Naoto Keicho
Journal:  Int J Med Sci       Date:  2013-06-15       Impact factor: 3.738

3.  Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.

Authors:  Emily M Eriksson; Chris E Keh; Steven G Deeks; Jeffrey N Martin; Frederick M Hecht; Douglas F Nixon
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

4.  CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.

Authors:  Lazar Vujanovic; Christopher Chuckran; Yan Lin; Fei Ding; Cindy A Sander; Patricia M Santos; Joel Lohr; Afshin Mashadi-Hossein; Sarah Warren; Andy White; Alan Huang; John M Kirkwood; Lisa H Butterfield
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

5.  Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarker.

Authors:  Takayo Ota; Tomoya Fukui; Yoshiro Nakahara; Takayuki Takeda; Junji Uchino; Takako Mouri; Keita Kudo; Saki Nakajima; Tomohiro Suzumura; Masahiro Fukuoka
Journal:  Thorac Cancer       Date:  2020-09-11       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.